Found: 15
Select item for more details and to access through your institution.
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolizationeligible patients.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1081479
- By:
- Publication type:
- Article
Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter Study.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2936, doi. 10.3390/cancers15112936
- By:
- Publication type:
- Article
Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6009, doi. 10.3390/cancers13236009
- By:
- Publication type:
- Article
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
High‐dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 8, p. 973, doi. 10.1111/apt.17909
- By:
- Publication type:
- Article
Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral Treatment.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/diagnostics12071757
- By:
- Publication type:
- Article
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 3, p. 500, doi. 10.3350/cmh.2024.0055
- By:
- Publication type:
- Article
Toward hepatitis C virus elimination using artificial intelligence.
- Published in:
- Clinical & Molecular Hepatology, 2024, v. 30, n. 2, p. 147, doi. 10.3350/cmh.2024.0135
- By:
- Publication type:
- Article
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 794, doi. 10.3350/cmh.2023.0057
- By:
- Publication type:
- Article
Transarterial radioembolization versus tyrosine ki- nase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 763, doi. 10.3350/cmh.2023.0076
- By:
- Publication type:
- Article
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 2, p. 363, doi. 10.3350/cmh.2023.0079
- By:
- Publication type:
- Article
Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study.
- Published in:
- Liver International, 2024, v. 44, n. 3, p. 799, doi. 10.1111/liv.15832
- By:
- Publication type:
- Article
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 627, doi. 10.1111/hepr.14021
- By:
- Publication type:
- Article
Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.263147
- By:
- Publication type:
- Article
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 7, p. 1, doi. 10.1002/jmv.29760
- By:
- Publication type:
- Article